We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.3%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$31.9B
AUM Growth
+$1.95B
(+6.5%)
Cap. Flow
+$433M
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
19.72%
Holding
2,075
New
328
Increased
694
Reduced
841
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$152M |
| 2 |
Ventas
VTR
|
+$139M |
| 3 |
Williams Companies
WMB
|
+$122M |
| 4 |
Healthpeak Properties
DOC
|
+$100M |
| 5 |
Chevron
CVX
|
+$78.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$276M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$110M |
| 3 |
Fortune Brands Innovations
FBIN
|
+$84.2M |
| 4 |
AGN
Allergan Inc
AGN
|
+$73.4M |
| 5 |
Morgan Stanley
MS
|
+$66.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.6% |
| 2 | Consumer Staples | 12.46% |
| 3 | Energy | 12.05% |
| 4 | Financials | 8.62% |
| 5 | Utilities | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
ExxonMobil
XOM
$653B
| $112M | 0.35% |
1,110,351
+474,728
| +75% | +$47.9M |
|
52
Blackrock
BLK
$170B
| $111M | 0.35% |
346,260
-406
| -0.1% | -$124K |
|
53
Vodafone
VOD
$37.2B
| $109M | 0.34% |
3,264,800
+128,124
| +4% | +$4.54M |
|
54
Unilever
UL
$143B
| $108M | 0.34% |
2,113,154
+1,058,557
| +100% | +$53M |
|
55
Welltower
WELL
$173B
| $104M | 0.33% |
1,667,302
+38,462
| +2% | +$2.42M |
|
56
Digital Realty Trust
DLR
$69.3B
| $104M | 0.33% |
1,779,510
-7,960
| -0.4% | -$446K |
|
57
Whirlpool
WHR
$2.45B
| $102M | 0.32% |
729,254
-262,463
| -26% | -$38.5M |
|
58
Devon Energy
DVN
$51.1B
| $101M | 0.32% |
1,270,296
+236,141
| +23% | +$17.2M |
|
59
General Motors
GM
$81.1B
| $100M | 0.31% |
2,756,588
+584,874
| +27% | +$20.4M |
|
60
Ameriprise Financial
AMP
$48.2B
| $99.5M | 0.31% |
828,937
+22,306
| +3% | +$2.5M |
|
61
Starbucks
SBUX
$119B
| $98.7M | 0.31% |
2,551,434
-30,452
| -1% | -$1.11M |
|
62
Apple
AAPL
$5.01T
| $98.2M | 0.31% |
4,227,984
-20,764
| -0.5% | -$442K |
|
63
Abbott
ABT
$191B
| $97.7M | 0.31% |
2,389,937
-374,554
| -14% | -$14.7M |
|
64
Coca-Cola
KO
$387B
| $96.9M | 0.3% |
2,287,881
+69,912
| +3% | +$2.84M |
|
65
Sherwin-Williams
SHW
$85.1B
| $93.2M | 0.29% |
1,351,167
+43,026
| +3% | +$2.87M |
|
66
Las Vegas Sands
LVS
$32B
| $92.7M | 0.29% |
1,215,765
-139,335
| -10% | -$10.6M |
|
67
Martin Marietta Materials
MLM
$34.2B
| $91M | 0.29% |
689,289
-5,251
| -0.8% | -$659K |
|
68
Freeport-McMoran
FCX
$84.6B
| $90.9M | 0.29% |
2,490,059
+1,032,491
| +71% | +$35.3M |
|
69
Westlake Corp
WLK
$9.26B
| $89.8M | 0.28% |
1,072,092
-31,568
| -3% | -$2.36M |
|
70
Expeditors International
EXPD
$22.2B
| $86.9M | 0.27% |
1,968,950
-120,450
| -6% | -$5.18M |
|
71
Thermo Fisher Scientific
TMO
$213B
| $86.9M | 0.27% |
736,276
-554
| -0.1% | -$65.2K |
|
72
Trane Technologies
TT
$98.9B
| $85M | 0.27% |
1,360,196
-16,286
| -1% | -$967K |
|
73
Wabtec
WAB
$49.8B
| $83.7M | 0.26% |
1,013,369
-577
| -0.1% | -$44.5K |
|
74
Medtronic
MDT
$113B
| $83.2M | 0.26% |
1,305,443
+701,326
| +116% | +$42.6M |
|
75
Amazon
AMZN
$2.47T
| $82.6M | 0.26% |
5,087,580
+1,505,220
| +42% | +$23.8M |
|
Similar funds
Federated Hermes's Q2 2014 Portfolio in Review
As of Q2 2014, Federated Hermes held 2,075 positions worth $31.9B, up 6.5% from $29.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Federated Hermes's Q2 2014 filing shows 328 new, 694 increased, 841 reduced and 117 closed positions. Its largest new stake was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M. The largest sale was AstraZeneca, an estimated $276M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Energy.
- Federated Hermes's largest Q2 2014 buy was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M.
- Federated Hermes added most to Illumina in Q2 2014, an estimated $152M increase.
- Federated Hermes's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $276M.
- Federated Hermes fully exited SIEMENS AKTIENGESELLSCHAFT ADS in Q2 2014, selling an estimated $39.7M.
- Federated Hermes's ten largest holdings make up 20% of its $31.9B portfolio in Q2 2014.
- Federated Hermes opened 328 new positions and closed 117 in Q2 2014.
- Federated Hermes's portfolio value rose 6.5% quarter-over-quarter to $31.9B.
Based on Federated Hermes's 13F filing for Q2 2014, filed 7 Aug 2014.